Emergent BioSolutions Inc. - Director's Dealing 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-11-07

Reporting Person: Richard Ronald (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-07	Common Stock	M	7893	$13.00	Acquired	28856	Direct
2018-11-07	Common Stock	S	7893	$70.00	Disposed	20963	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-07	Stock Option (Right to Buy)	$13.00	M	7893	Disposed	2020-05-22	Comon Stock (7893)	Direct

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.

F2: Consists of an option granted under the company's stock incentive plan as amended and restated.

F3: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.